Oligonucleotide Synthesis Market to Reach US$ 3,971.72 Million at CAGR of 11.1% by 2027 | The Insight Partners
Biotechnology Oligonucleotide Synthesis Market to...

Oligonucleotide Synthesis Market to 2027- Global Analysis and Forecasts By Product (Synthesized Oligonucleotides, Reagents, and Equipment), Application (Research, Diagnostics, and Therapeutics), End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Other End Users), and Geography

Publication Month: Mar 2019 | Report Code: TIPBT00002549 | No. of Pages: 150 | Category: Biotechnology | Status: Published

The global oligonucleotide synthesis market accounted to US$ 1,584.16 Mn in 2018 and is expected to grow at a CAGR of 11.1% during the forecast period 2019 - 2027, to account to US$ 3,971.72 Mn by 2027.

 

The Asia Pacific oligonucleotide synthesis market is expected to grow at highest rate during the forecast period owing to higher number of research & development and biotechnological industry in countries such as, Japan and China, prevalence of cancer as well as strategic developments made by the companies. In addition, emergence of new local players with competitive product portfolio are expected to fuel the market growth in Asia Pacific region.      

Exhibit: Lucrative Regional Markets


 

Market Insights

Increasing Applications of Synthesized Oligonucleotides

Oligonucleotides have many applications in research, diseases diagnosis, therapeutics, forensic, drug discovery, agriculture and many more. Oligonucleotides are used in many biological and forensic applications as sequence-specific binding agents can help in identifying presence of a specific target DNA sequence. Synthetic oligonucleotides are short stretches of single stranded DNA fragments assembled by chemical synthesis. There is hardly a field in biology in which synthetic DNA has not been used or does not have the potential to be used. The main reason for such a turnabout is the simultaneous developments of methods for the rapid and efficient synthesis of oligonucleotides and the advent of molecular biology techniques. Researchers are also using oligonucleotides to produce more efficient, greener chemical synthesis. By assembling oligonucleotides together into longer fragments that encode synthetic genes, bacteria or yeast cells can be instructed to produce specific enzymes (a type of protein). Oligonucleotides has tremendous potential for treating wide range of medical conditions. They enable the development of therapeutics as the malfunctioning genes can be targeted, manipulated, silenced and/or modulated. Ionis Pharmaceuticals has dedicated its existence to oligonucleotide therapeutic development, particularly antisense oligonucleotide (ASO) therapeutics. Thus, the promising potential of synthesized oligonucleotides in various fields drives the market growth.

 

Increasing Investments for Synthetic Biology

Synthetic biology is an upcoming field and industry, which has numerous applications in the chemical, agriculture, pharmaceutical and energy sectors. There are various start-up companies that are providing the products/services for the biological processes. Companies such as, Benchling which operates in CAD Tools, GenScript offers gene synthesis, Ginkgo Bioworks works for the organism engineering, Transcriptis which is into bioinformatics operates for cloud labs/automation, Glowee offers consumer products, among the other companies operating in the synthetic biology.

 

Globally, the synthetic biology has set benchmark with its innovations and the dynamic results. The industry has attracted various global leaders to invest for synthetic biology. For instance, synthetic DNA manufacturer DNA Script has announced a Series A fundraising of 11 million euros ($13 million) led by Illumina Ventures, with additional investment from Merck Ventures BV, the corporate venture arm of Merck KGaA, plus existing investors Sofinnova Partners, Kurma Partners, and Idinvest Partners. Owing to the rising investment for the synthetic biology companies, the need and demand for the synthetic biology for the development of the new techniques may increase the market in the future years.

 

Product Insights

Global oligonucleotide synthesis market, based on product was segmented into synthesized oligonucleotides, reagents, and equipment. In 2018, the synthesized oligonucleotides segment held a largest market share of 48.3% of the oligonucleotide synthesis market, by product. This segment is also expected to dominate the market in 2027 owing to increasing use of the product in research and diagnostic purposes. The segment is also anticipated to witness the growth at a significant rate during the forecast period, 2018 to 2027.

 

Application Insights

Global oligonucleotide synthesis market, based on application was segmented into research, diagnostics, and therapeutics. Research segment is anticipated to grow at a CAGR of 45.3% during the forecast period. The availability of funds as well as supportive government policies are expected to boost the growth of the segment during the forecast period. The segment is also expected to retain its position among the other applications during the year 2027.

 

Exhibit: Oligonucleotide synthesis Market, by Application


  

Strategic Insights

Strategic acquisition and product launches were observed as the most adopted strategy in global oligonucleotide synthesis industry. Few of the recent product launch and acquisitions are listed below:

 

2018: Twist Bioscience has developed sample preparation products for customers performing next-generation sequencing experiments and analysis. The Twist Human Core Exome Kit includes all the tools needed for library construction, target capture and enrichment to prepare a sample for sequencing.

 

2018: Twist Bioscience Corporation expanded its North American operations with establishing a new office in San Diego area. The office supports sales and marketing and other corporate administrative functions and will be the headquarters for customer support for the company’s recently-launched solutions to enhance next-generation sequencing.

 

2018: EVONETIX LTD pioneering an innovative approach to scalable and high-fidelity gene synthesis, and LioniX International, a leading global provider of customised microsystem solutions in scalable production volumes, collaborated to scale up production of prototype microelectromechanical systems (MEMs) for DNA synthesis.

 

OLIGONUCLEOTIDE SYNTHESIS - MARKET SEGMENTATION

 

By Product

  • Synthesized Oligonucleotides
    • Primers
    • Probes
    • Large-Scale Synthesis Oligonucleotides
    • Others
  • Reagents
  • Equipment

By Application

  • Research
  • Diagnostics
  • Therapeutics

By End User

  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Other End Users

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South America (SAM)
    • Brazil
    • Argentina

Company Profiles

  • Molecular Assemblies
  • Twist Biosciences
  • Evonetix
  • DNA Script
  • Nuclera Nucleics
  • Camena Bioscience
  • Synthomics
  • Ansa Biotechnologies
  • Helixworks
  • Iridia
  • Keasling Laboratories

1.        INTRODUCTION

1.1    Scope of the Study

1.2    The Insight Partners Research Report Guidance

1.3    market segmentation

1.3.1    Global Oligonucleotide Synthesis Market – By Product

1.3.2    Global Oligonucleotide Synthesis Market – By Application

1.3.3    Global Oligonucleotide Synthesis Market – By End User

1.3.4    Global Oligonucleotide synthesis Market – By Geography

2.        Global Oligonucleotide Synthesis Market –  Key takeaways

3.        Research Methodology

3.1.1    Coverage

3.1.2    Secondary Research

3.1.3    Primary Research

4.        Global Oligonucleotide synthesis market – market landscape

4.1    overview

4.2    PEST Analysis

4.2.1    North America PEST Analysis

4.2.2    Europe PEST Analysis

4.2.3    Asia Pacific PEST Analysis

4.2.4    Middle East & Africa PEST Analysis

4.2.5    South & Central America PEST Analysis

4.3    Key Market Drivers

4.3.1    Increasing Applications of Synthesized Oligonucleotides

4.3.2    Increasing Investments for Synthetic Biology

4.3.3    Technological Advancements Genome Editing Tools

4.4    Key Market Restraints

4.4.1    Renewed Regulations for Biotechnology

4.4.2    Lack Of Skilled Professionals In Life Science Industry

4.5    Key Market Opportunities

4.5.1    Collaborations — The Future of Innovation

4.6    Future Trends

4.6.1    Advancements in Synthetic Biology

4.7    Impact analysis

5.        Oligonucleotide Synthesis market –  Global Analysis

5.1    global Oligonucleotide Synthesis market Revenue Forecasts and Analysis

5.2    global Oligonucleotide Synthesis market, By Geography - Forecasts and Analysis

5.3    PERFORMANCE OF KEY PLAYERS

5.3.1    Thermo Fisher Scientific Inc.

5.3.2    GenScript

5.4    expert opinions

6.        Global oligonucleotide synthesis market Analysis – By Product

6.1    Overview

6.2    GLOBAL Oligonucleotide synthesis market, BY product, 2018 & 2027 (%)

6.3    Synthesized Oligonucleotides Market

6.3.1    Overview

6.3.2    Global Synthesized Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)

6.3.3    Primers Market

6.3.3.1   Overview

6.3.3.2   Global Primers Market Revenue and Forecasts to 2027 (US$ Mn)

6.3.4    Probes Market

6.3.4.1   Overview

6.3.4.1.1  Global Probes Market Revenue and Forecasts to 2027 (US$ Mn)

6.3.4.2   Large-Scale Synthesis Oligonucleotides Market

6.3.4.2.1  Overview

6.3.4.2.2  Global Large-Scale Synthesis Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)

6.3.4.3   Others Market

6.3.4.3.1  Overview

6.3.4.3.2  Global Others Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)

6.4    Reagents Market

6.4.1    Overview

6.4.2    Global Reagents Market Revenue and Forecasts to 2027 (US$ Mn)

6.5    Equipment Market

6.5.1    Overview

6.5.2    Global Equipment Market Revenue and Forecasts to 2027 (US$ Mn)

7.        Global Oligonucleotide synthesis market Analysis – By application

7.1    Overview

7.2    GLOBAL Oligonucleotide synthesis market, BY application, 2018 & 2027 (%)

7.3    research Market

7.3.1    Overview

7.3.2    Global Research Market Revenue and Forecasts to 2027 (US$ Mn)

7.4    Diagnostics Market

7.4.1    Overview

7.4.2    Global Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

7.5    therapeutics Market

7.5.1    Overview

7.5.2    Global Therapeutics Medicine Market Revenue and Forecasts to 2027 (US$ Mn)

8.        Global oligonucleotide synthesis market Analysis – By end user

8.1    Overview

8.2    GLOBAL Oligonucleotide synthesis market, BY end user, 2018 & 2027 (%)

8.3    Academic Research Institutes Market

8.3.1    Overview

8.3.2    Global Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

8.4    Diagnostic Laboratories Market

8.4.1    Overview

8.4.2    Global Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

8.5    Pharmaceutical & Biotechnology Companies Market

8.5.1    Overview

8.5.2    Global Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)

8.6    Other end users Market

8.6.1    Overview

8.6.2    Global Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)

9.        Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 – Geography analysis

9.1    North America Oligonucleotide synthesis market Revenue and Forecasts to 2027

9.1.1    North America Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.2    North America Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.2.1   North America Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.3    North America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application  (US$ Mn)

9.1.4    North America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.5    North America Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)

9.1.6    US Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.1   US Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.2   US Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.6.2.1  US Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.6.3   US Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.1.6.4   US Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.7    Canada Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.1   Canada Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.2   Canada Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.7.2.1  Canada Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.3   Canada Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.1.7.4   Canada Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.8    Mexico Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.1   Mexico Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.2   Mexico Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.8.2.1  Mexico Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.8.3   Mexico Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.1.8.4   Mexico Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2    Europe Oligonucleotide Synthesis market Revenue and Forecasts to 2027

9.2.1    Europe Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.2    Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.2.2.1   Europe Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.3    Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.2.4    Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.5    Europe Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)

9.2.6    UK Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.6.1   UK Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.6.2   UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.2.6.2.1  UK Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.6.3   UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.2.6.4   UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.7    Germany Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.1   Germany Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.2   Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.2.7.2.1  Germany Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.7.3   Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.2.7.4   Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.8    France Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.8.1   France Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.8.2   France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.2.8.2.1  France Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.8.3   France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.2.8.4   France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.9    Italy Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9.1   Italy Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9.2   Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.2.9.2.1  Italy Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.9.3   Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.2.9.4   Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.10  Spain Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.10.1 Spain Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.10.2 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.2.10.2.1 Spain Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.10.3 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.2.10.4 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3    Asia Pacific Oligonucleotide Synthesis Market Revenue and Forecasts to 2027

9.3.1    Asia Pacific Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.2    Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.3.2.1   Asia Pacific Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.3    Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.3.4    Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.5    Asia Pacific Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)

9.3.6    China Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.6.1   China Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.6.2   China Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.3.6.2.1  China Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.6.3   China Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.3.6.4   China Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.7    India Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.1   India Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.2   India Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.3.7.2.1  India Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.7.3   India Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.3.7.4   India Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.8    Japan Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.8.1   Japan Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.8.2   Japan Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.3.8.2.1  Japan Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.8.3   Japan Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.3.8.4   Japan Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.9    Australia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.9.1   Australia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.9.2   Australia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.3.9.2.1  Australia Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.9.3   Australia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.3.9.4   Australia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.10  South Korea Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.10.1 South Korea Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.10.2 South Korea Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.3.10.2.1 South Korea Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.10.3 South Korea Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.3.10.4 South Korea Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4    Middle East & Africa Oligonucleotide Synthesis Market Revenue and Forecasts to 2027

9.4.1    Middle East & Africa Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.2    Middle East & Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Product  (US$ Mn)

9.4.2.1   Middle East & Africa Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.4.3    Middle East & Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.4.4    Middle East & Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4.5    Middle East & Africa Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)

9.4.6    Saudi Arabia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.6.1   Saudi Arabia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.6.2   Saudi Arabia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.4.6.2.1  Saudi Arabia Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.4.6.3   Saudi Arabia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.4.7    South Africa Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.7.1   South Africa Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.7.2   South Africa Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.4.7.2.1  South Africa Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.4.7.3   South Africa Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.4.7.4   South Africa Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4.8    UAE Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.8.1   UAE Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.8.2   UAE Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.4.8.2.1  UAE Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.4.8.3   UAE Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.4.8.4   UAE Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.5    South and Central America Oligonucleotide Synthesis Market Revenue and Forecasts to 2027

9.5.1    South and Central America Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.2    South and Central America Oligonucleotide Synthesis market Revenue And Forecasts to 2027,  By Product (US$ Mn)

9.5.2.1   South and Central America Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type  (US$ Mn)

9.5.3    South and Central America Oligonucleotide Synthesis market Revenue And Forecasts to 2027,  By Application (US$ Mn)

9.5.4    South and Central America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.5.5    South and Central America Oligonucleotide Synthesis Market Revenue and Forecasts to 2027,  By Country (%)

9.5.6    Argentina Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.6.1   Argentina Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.6.2   Argentina Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.5.6.2.1  Argentina Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.5.6.3   Argentina Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.5.6.4   Argentina Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.5.7    Brazil Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.7.1   Brazil Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.7.2   Brazil Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.5.7.2.1  Brazil Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.5.7.3   Brazil Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.5.7.4   Brazil Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.       Oligonucleotide Synthesis MARKET –Industry Landscape

10.1   Overview

10.2   Comparative Company Analysis

10.3   Growth Strategies done by the companies in the Market, (%)

10.4   Organic Developments

10.4.1  Overview

10.5   Inorganic developments

10.5.1  Overview

11.       oligonucleotide synthesis Market–Key company profiles

11.1   Thermo Fisher Scientific Inc.

11.1.1  Key Facts

11.1.2  Business Description

11.1.3  Financial Overview

11.1.4  Product Portfolio

11.1.5  SWOT Analysis

11.1.6  Key Developments

11.2   GenScript

11.2.1  Key Facts

11.2.2  Business Description

11.2.3  Financial Overview

11.2.4  Product Portfolio

11.2.5  SWOT Analysis

11.2.6  Key Developments

11.3   Synthomics, Inc.

11.3.1  Key Facts

11.3.2  Business Description

11.3.3  Financial Overview

11.3.4  Product Portfolio

11.3.5  SWOT Analysis

11.3.6  Key Developments

11.4   Ansa Biotechnologies, Inc.

11.4.1  Key Facts

11.4.2  Business Description

11.4.3  Financial Overview

11.4.4  Product portfolio

11.4.5  SWOT Analysis

11.4.6  Key Developments

11.5   Iridia, Inc.

11.5.1  Key Facts

11.5.2  Business Description

11.5.3  Financial overview

11.5.4  Product Portfolio

11.5.5  SWOT Analysis

11.5.6  Key Developments

11.6   Helixworks

11.6.1  Key Facts

11.6.2  Business Description

11.6.3  Financial overview

11.6.4  Product Portfolio

11.6.5  SWOT Analysis

11.6.6  Key Developments

11.7   Keasling Lab

11.7.1  Key Facts

11.7.2  Business Description

11.7.3  Financial Overview

11.7.4  Product Portfolio

11.7.5  SWOT Analysis

11.7.6  Key Developments

11.8   Molecular Assemblies

11.8.1  Key Facts

11.8.2  Business Description

11.8.3  Financial Overview

11.8.4  Product Portfolio

11.8.5  SWOT Analysis

11.8.6  Key Developments

11.9   Twist Bioscience

11.9.1  Key Facts

11.9.2  Business Description

11.9.3  Financial Overview

11.9.4  Product portfolio

11.9.5  SWOT Analysis

11.9.6  Key Developments

11.10 Evonetix

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Financial overview

11.10.4 Product Portfolio

11.10.5 SWOT Analysis

11.10.6 Key Developments

11.11 DNA Script

11.11.1 Key Facts

11.11.2 Business Description

11.11.3 Financial overview

11.11.4 Product Portfolio

11.11.5 SWOT Analysis

11.11.6 Key Developments

11.12 Nuclera Nucleics Ltd.

11.12.1 Key Facts

11.12.2 Business Description

11.12.3 Financial Overview

11.12.4 Product Portfolio

11.12.5 SWOT Analysis

11.12.6 Key Developments

11.13 Camena Bio

11.13.1 Key Facts

11.13.2 Business Description

11.13.3 Financial Overview

11.13.4 Product Portfolio

11.13.5 SWOT Analysis

11.13.6 Key Developments

12.       Appendix

12.1   About The Insight Partners

12.2   Glossary of Terms

 

list of tables

TABLE 1.      North america Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 2.      North America synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type  (US$ Mn)

TABLE 3.      North America Oligonucleotide Synthesis market Revenue And Forecasts to 2027,  By application (US$ Mn)

TABLE 4.      North America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 5.      US Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 6.      US synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 7.      US Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 8.      US Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 9.      Canada Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 10.    Canada synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type  (US$ Mn)

TABLE 11.    Canada Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 12.    Canada Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 13.    Mexico Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 14.    Mexico synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type  (US$ Mn)

TABLE 15.    Mexico Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 16.    Mexico Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 17.    Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 18.    Europe synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type  (US$ Mn)

TABLE 19.    Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application  (US$ Mn)

TABLE 20.    Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 21.    UK Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 22.    UK synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 23.    UK Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 24.    UK Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 25.    Germany Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 26.    Germany synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 27.    Germany Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application  (US$ Mn)

TABLE 28.    Germany Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user  (US$ Mn)

TABLE 29.    France Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 30.    France synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 31.    France Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application  (US$ Mn)

TABLE 32.    France Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 33.    Italy Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 34.    Italy synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type  (US$ Mn)

TABLE 35.    Italy Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 36.    Italy Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 37.    Spain Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 38.    Spain synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type  (US$ Mn)

TABLE 39.    Spain Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application  (US$ Mn)

TABLE 40.    Spain Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 41.    Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product  (US$ Mn)

TABLE 42.    Asia Pacific synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type  (US$ Mn)

TABLE 43.    Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 44.    Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user  (US$ Mn)

TABLE 45.    China Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 46.    China synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 47.    China Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application  (US$ Mn)

TABLE 48.    China Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 49.    India Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 50.    India synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 51.    India Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 52.    India Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 53.    Japan Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 54.    Japan synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 55.    Japan Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application  (US$ Mn)

TABLE 56.    Japan Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 57.    Australia Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product  (US$ Mn)

TABLE 58.    Australia synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type  (US$ Mn)

TABLE 59.    Australia Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 60.    Australia Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user  (US$ Mn)

TABLE 61.    South Korea Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 62.    South Korea synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type  (US$ Mn)

TABLE 63.    South Korea Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 64.    South Korea Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 65.    Middle East & Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027,  By product (US$ Mn)

TABLE 66.    Middle East & Africa synthesized Oligonucleotides market Revenue And Forecasts to 2027,  By Type (US$ Mn)

TABLE 67.    Middle East & Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027,  By application (US$ Mn)

TABLE 68.    Middle East & Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027,  By end user (US$ Mn)

TABLE 69.    Saudi Arabia Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 70.    Saudi Arabia synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type  (US$ Mn)

TABLE 71.    Saudi Arabia Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 72.    Saudi Arabia Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 73.    South Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 74.    South Africa synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type  (US$ Mn)

TABLE 75.    South Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 76.    South Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 77.    UAE Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 78.    UAE synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 79.    UAE Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 80.    UAE Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 81.    South and Central America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 82.    South and Central America synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 83.    South and Central America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 84.    South and Central America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 85.    Argentina Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product  (US$ Mn)

TABLE 86.    Argentina synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type  (US$ Mn)

TABLE 87.    Argentina Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 88.    Argentina Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user  (US$ Mn)

TABLE 89.    Brazil Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)

TABLE 90.    Brazil synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 91.    Brazil Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application  (US$ Mn)

TABLE 92.    Brazil Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 93.    Organic Developments Done By Companies

TABLE 94.    Inorganic developments done by Companies

TABLE 95.    Glossary of Terms, Oligonucleotide Synthesis market

 

list of figures

FIGURE 1.    Oligonucleotide synthesis market Segmentation

FIGURE 2.    oligonucleotide synthesis Segmentation, by region

FIGURE 3.    Asia Pacific Oligonucleotide Synthesis market, Revenue (US$ Mn), By Geography 2018 & 2027

FIGURE 4.    Global Oligonucleotide Synthesis Market By product, Market Share (%), 2018

FIGURE 5.    Global Oligonucleotide Synthesis Market By application, Market Share (%), 2018

FIGURE 6.    Global Oligonucleotide Synthesis Market By end user, Market Share (%), 2018

FIGURE 7.    North America : PEST Analysis

FIGURE 8.    Europe : PEST Analysis

FIGURE 9.    Asia - Pacific : PEST Analysis

FIGURE 10.   Middle East & Africa : PEST Analysis

FIGURE 11.   South & Central America : PEST Analysis

FIGURE 12.   oligonucleotide synthesis market impact analysis of driver and restraints

FIGURE 13.   global Oligonucleotide Synthesis market – Revenue Forecasts and Analysis – 2018- 2027

FIGURE 14.   global Oligonucleotide Synthesis market – by geography Forecasts and Analysis – 2018- 2027

FIGURE 15.   Global Oligonucleotide synthesis market By Product, 2018 & 2027 (%)

FIGURE 16.   Global Synthesized oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 17.   Global primers Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 18.   Global Probes Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 19.   Global Large-Scale Synthesis Oligonucleotides Market Revenue and Forecasts to 2027  (US$ Mn)

FIGURE 20.   Global others Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 21.   Global Reagents Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 22.   Global Equipment Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 23.   Global Oligonucleotide synthesis market By application, 2018 & 2027 (%)

FIGURE 24.   Global Research Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 25.   Global Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 26.   Global therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 27.   Global Oligonucleotide synthesis market By end user, 2018 & 2027 (%)

FIGURE 28.   Global Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 29.   Global diagnostic laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 30.   Global Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 31.   Global Other end users Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 32.   North america Oligonucleotide Synthesis Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 33.   North america Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 34.   North America Oligonucleotide Synthesis Market Revenue And Forecasts to 2027,  By Country (%)

FIGURE 35.   US Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 36.   Canada Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 37.   Mexico Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 38.   Europe Oligonucleotide Synthesis Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 39.   Europe Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 40.   Europe Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 41.   UK Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 42.   Germany Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 43.   France Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 44.   Italy Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 45.   Spain Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 46.   Asia Pacific Oligonucleotide Synthesis Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 47.   Asia Pacific Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 48.   Asia Pacific Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 49.   China Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 50.   India Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 51.   Japan Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 52.   Australia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 53.   South Korea Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 54.   Middle East & Africa Oligonucleotide Synthesis Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 55.   Middle East & Africa Oligonucleotide Synthesis Market Revenue and Forecasts to 2027  (US$ Mn)

FIGURE 56.   Middle East & Africa Oligonucleotide Synthesis Market Revenue And Forecasts to 2027,  By Country (%)

FIGURE 57.   Saudi Arabia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 58.   South Africa Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 59.   UAE Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 60.   South and Central America Oligonucleotide Synthesis Market REVENUE, by Country,  2018 (US$ MN)

FIGURE 61.   South and Central America Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 62.   South and Central America Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 63.   Argentina Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 64.   Brazil Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 65.   Comparative Company Analysis

FIGURE 66.   Growth Strategies done by the companies in the Market, (%)

 

 

The List of Companies

  1. Thermo Fisher Scientific Inc.
  2. GenScript
  3. Molecular Assemblies
  4. Twist Biosciences
  5. Evonetix
  6. DNA Script
  7. Nuclera Nucleics
  8. Camena Bioscience
  9. Synthomics
  10. Ansa Biotechnologies
  11. Helixworks
  12. Iridia
  13. Keasling Laboratories
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the oligonucleotide synthesis market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global oligonucleotide synthesis market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550
Get Sample PDF
Inquire before Buying
Inquire for Discount
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2019 - The Insight Partners. All rights reserved